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ABSTRACT The pancreatic-islet-enriched transcription factors MafA and MafB have
unique expression patterns in  cells in rodents. MafA is speciﬁcally expressed in 
cells and is a key regulatory factor for maintaining adult -cell function, whereas
MafB plays an essential role in -cell development during embryogenesis, and its ex-
pression in  cells gradually decreases and is restricted to  cells after birth in ro-
dents. However, it was previously observed that MafB started to be reexpressed in
insulin-positive (insulin)  cells in MafA-deﬁcient adult mice. To elucidate how
MafB functions in the adult  cell under MafA-deﬁcient conditions, we generated
MafA and MafB double-knockout (A0B0) mice in which MafB was speciﬁcally deleted
from  cells. As a result, the A0B0 mice became more vulnerable to diabetes under
a high-fat diet (HFD) treatment, with impaired islet formation and a decreased num-
ber of insulin  cells because of increased -cell apoptosis, indicating MafB can
take part in the maintenance of adult  cells under certain pathological conditions.
KEYWORDS diabetes mellitus, MafA, MafB, pancreatic  cells
Diabetes mellitus (DM) is a serious chronic disease that causes the deaths of millionsof people throughout the world. DM occurs when blood glucose homeostasis is
impaired because either the pancreas is no longer producing insulin, which is called
type 1 diabetes (T1DM), or the cells in the body have difﬁculty responding to insulin
properly, which is called type 2 diabetes (T2DM) (1). Pancreatic  cells of the islets of
Langerhans synthesize and secrete insulin in response to elevated blood glucose and
nutrition to maintain blood glucose homeostasis (2). Therefore, studying the detailed
mechanism of -cell development, maintenance, and function is not only crucial for
understanding the DM disease process but also important for providing advanced
treatment of the disease.
MafA and MafB, members of the large Maf protein family, are known as islet-
enriched transcription factors that play important roles in -cell development, main-
tenance, and function (3). Their expression patterns in  cells are different from each
other. In rodents, MafB starts to be expressed around embryonic day 10.5 (E10.5) in the
pancreatic progenitor cells of both  and  cells. MafB expression in  cells gradually
decreases and is restricted to  cells after birth. MafA, on the other hand, starts to be
expressed at E13.5 and is expressed only in  cells throughout adulthood (4, 5). Several
studies on MafA and MafB mutant mice have revealed that MafA is a fundamental
regulatory factor for -cell function. The phenotype of MafA-deﬁcient adult mice
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showed reduced expression of insulin secretion genes, fasting hyperglycemia, and
impaired glucose-stimulated insulin secretion (6, 7). MafB functions in  cells only in the
embryonic stage, and MafB knockout (KO) embryos display decreased insulin-positive
(insulin) cell numbers; this phenomenon disappears soon after birth (8, 9), indicating
that MafB plays important roles in -cell development but not in -cell function in the
adult stage.
In a previous study, we observed that MafB is expressed in many insulin cells in
MafA-deﬁcient adult mice compared with wild-type (WT) mice (7). We have also found
that MafA knockout, MafB heterozygote (A0B1) adult mice display more severe hyper-
glycemia than do A0 adult mice (10). Based on these results, we hypothesized that MafB
can take part in the maintenance of adult -cell function under pathological conditions.
To investigate whether MafB takes part in adult -cell activity under MafA-deﬁcient
conditions, we generated MafA, MafB double-knockout (A0B0) mice in which MafB was
speciﬁcally deleted in  cells and compared its phenotype with those of A0 and WT
mice.
RESULTS
The effect of MafB on insulin-producing cells gradually decreases after birth. It
is well known that MafB regulates the transcription of genes needed for -cell and
-cell production; thus, absence of MafB results in a reduction in - and -cell numbers
during embryonic development (8, 9, 11, 12). To investigate MafB regulation of  cells
alone, we generated MafB conditional-knockout (CKO) mice in which MafB was specif-
ically deleted from  cells by Cre-loxP recombination. MafB deletion from  cells was
conﬁrmed by immunoﬂuorescence staining at the embryonic stage (see Fig. S1A in the
supplemental material). We analyzed the histology of the pancreatic islets of CKO mice
both prenatally and postnatally. MafB deﬁciency caused a minor effect on insulin-
positive-cell proliferation, since reduced expression of insulin cells in CKO mice was
observed at E18.5. Furthermore, this change was reversed after birth, because MafB is
no longer expressed in  cells during postnatal development under normal conditions
(Fig. 1A).
To check whether the prenatal defect in -cell development could affect glucose
metabolism postnatally in CKO mice, we measured the fasting blood glucose level
and insulin content in the neonatal stage. Although the fasting blood glucose level
was slightly elevated in CKO mice at postnatal day 7 (P7) compared to the control
group (control, 125 18 mg/dl; MafB CKO, 156 7 mg/dl), the insulin content did not
show any signiﬁcant change at that age (control, 0.15 0.02 ng/g; MafB CKO,
0.19 0.03 ng/g) (Fig. 1B and C). Furthermore, the fasting glucose level became
comparable to that of the control group at a later stage, along with unchanged glucose
tolerance or glucose-stimulated insulin secretion (Fig. 1D to F).
A0B0 mice showed mildly impaired glucose tolerance compared to WT and
A0B2 mice. In our previous study, we observed that MafB was reexpressed in adult 
cells under MafA-deﬁcient conditions (7). To elucidate the role of MafB in  cells
postnatally in the absence of MafA, we generated A0B0 mice by mating the MafB CKO
mice with the MafA-null knockout mice (A0B2). Body weights and fasting blood glucose
levels were comparable within each group of mice (Fig. 2A and B). Next, we compared
the glucose clearance abilities of WT, A0B2, and A0B0 mice by an intraperitoneal
glucose tolerance test (ipGTT). Blood glucose levels were rapidly increased in both A0B0
and A0B2 mice after glucose administration and were maintained at high levels
compared with that of WT mice for at least 2 h. A0B0 mice showed a signiﬁcantly
elevated blood glucose level relative to that of A0B2 mice at 30 min (A0B0,
693 119 mg/dl; A0B2, 578 27 mg/dl; P 0.05) (Fig. 2C). A0B0 mice became more
intolerant of glucose 6 months later, as their blood glucose levels reached nearly
900 mg/dl 1 h after glucose administration and were still at a high level (422 130 mg/
dl) at 2 h. To investigate the mechanism of this glucose intolerance, we analyzed the
insulin secretion of the mice in response to glucose stimulation. Plasma insulin levels in
each mouse group were not signiﬁcantly different from each other before glucose
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stimulation. Both A0B2 and A0B0 mice failed to respond to an elevated glucose level,
since there was no acute insulin secretion after glucose administration. However, the
insulin level of the A0B0 mice was comparable to that of the A0B2 mice (A0B2 versus
A0B0, 0 min, 0.56 0.27 ng/g versus 0.96 0.5 ng/g; 2 min, 0.37 0.04 ng/g
FIG 1 The effect of MafB on insulin-producing  cells does not last into adulthood. (A) Insulin (green) and glucagon
(red) immunoreactivities in MafBﬂox/ﬂox::Cre and MafB CKO mice at E18.5, P7, and 6 months of age (6M). (B) Fasting
blood glucose (FBG) levels of mice at P7. Six or 7 mice from each genotype were used. F/F, MafBﬂox/ﬂox. (C) Insulin
contents of mice at P7. Four mice from each genotype were used. (D) Fasting blood glucose levels of mice at 6
months of age. Five mice from each genotype were used. (E) Glucose tolerance tests (ipGTT) after intraperitoneal
loading with 2 g glucose/kg were performed on 6-month-old mice of the indicated genotypes following a 16-h
fasting period. (F) In vivo GSIS tests after intraperitoneal loading with 3 g glucose/kg were performed on
6-month-old mice of the indicated genotypes following a 16-h fasting period. The data are from 5 male mice of
each genotype. *, P 0.05. The error bars indicate SD.
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versus 0.46 0.04 ng/g; 5 min, 0.28 0.20 ng/g versus 0.41 0.02 ng/g; 15 min,
0.27 0.16 ng/g versus 0.49 0.02 ng/g) (Fig. 2D). These results indicate the
glucose tolerance capacity was impaired in a mild range in A0B0 mice, while their
insulin secretion capacity in response to glucose stimulation was unchanged compared
to A0B2 mice.
Impaired islet structures were observed in both A0B2 and A0B0 pancreases but
more signiﬁcantly in A0B0 mice. Since A0B0 mice displayed more impaired glucose
tolerance, we next analyzed the pancreatic islets of A0B0 mice histologically and
compared them with those of WT and A0B2 mice. Using anti-insulin and anti-glucagon
antibodies, the numbers and percentages of insulin- and glucagon-positive cells were
measured (Fig. 3A, B, and E). There was a signiﬁcant reduction in insulin-expressing cell
numbers in the pancreatic islets of both A0B2 and A0B0 mice compared to WT mice.
However, the difference between the A0B2 and A0B0 mouse groups was insigniﬁcant
(Fig. 3A and B). The quantitative PCR results from the isolated pancreatic islets showed
FIG 2 Deletion of MafB in  cells showing slightly impaired glucose tolerance in the A0B0 group compared to the
WT and A0B2 groups. (A and B) Body weight and fasting blood glucose (FBG) levels of mice from different
genotypes over 20 weeks. The data are from 3 to 6 male mice of each genotype. (C) Glucose tolerance tests (ipGTT)
after intraperitoneal loading with 2 g glucose/kg were performed on 3- month-old (right) and 9-month-old (left)
female mice of the indicated genotypes following a 16-h fasting period. (D) In vivo GSIS testing after intraperitoneal
loading with 3 g glucose/kg was performed on 9-month-old female mice of the indicated genotypes following a
16-h fasting period. The data are from 3 or 4 female mice of each genotype. *, A0B2 and WT, P 0.05; **, A0B02
and WT, P 0.01; #, A0B0 and WT, P 0.05; ##, A0B0 and WT, P 0.01; ※, A0B2 and A0B0, P 0.05; ※※, A0B2 and
A0B0, P 0.01. The error bars indicate SD.
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that the amounts of mouse insulin genes Ins1 and Ins2 were reduced in A0B2 and A0B0
islets in comparison to WT islets, while they were comparable within the groups
(Fig. 3D). Whole pancreatic insulin content measurements also showed the same results
(Fig. 3C).
The number of glucagon-expressing cells, on the other hand, showed a signiﬁcant
increase in A0B0 islets compared to that in WT islets (WT, 24.97 6.7; A0B0, 43.9 9.4)
(Fig. 3E). The ratio of glucagon-expressing cells to insulin-expressing cells in A0B0 islets
FIG 3 Impaired islet structure is more signiﬁcant in the A0B0 pancreas than in the WT and A0B2 pancreas. (A)
Insulin (green) and glucagon (red) immunoreactivities in mouse pancreatic islets from 9-month-old female mice of
each genotype. (B) Insulin-positive cell number/total islet cell number ratio in pancreatic islets of each mice group.
(C) Insulin contents of mice from different genotypes. The data are from 3 to 9 males of each genotype at 9 months
of age. (D) Ins1 and Ins2 gene expression in islets from each genotype. The amount of each transcript was
normalized to the amount of the Hprt transcript. The expression levels of the Ins1 and Ins2 genes in the WT were
set as 1. The data are from 3 or 4 female mice of each genotype at 9 months. (E) Glucagon-positive cell
number/total islet cell number ratio in pancreatic islets of each genotype. (F) Glucagon contents of mice from
different genotypes. The data are from 3 to 9 males of each genotype at 9 months. (G) Gcg gene expression of islets
from each genotype. The amount of glucagon transcript was normalized by the amount of the Hprt transcript. (H)
Glucagon-positive cell number/insulin-positive cell number ratio in pancreatic islets of each genotype. The data are
from 3 or 4 female mice of each genotype at 9 months. *, P 0.05; **, P 0.01; NS, not signiﬁcant. The error bars
indicate SD.
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also increased correspondingly and showed a signiﬁcant difference from WT and A0B2
islets (WT, 0.32 0.13; A0B2, 0.53 0.16; A0B0, 0.87 0.10) (Fig. 3H). These results
indicate that structural destruction was more prominent in the A0B0 mouse group than
in the other groups. However, the relative mRNA expression of glucagon and the whole
pancreatic glucagon content were comparable among the groups (Fig. 3G and F,
respectively).
A0B0 mice developed diabetes 5 months after high-fat-diet (HFD) treatment.
The phenotype of MafA knockout mice in our study, which had a C57BL/6J background,
was relatively mild compared with that of mice with an ICR background. In mice from
the ICR strain, a deﬁciency of MafA contributed to fasting hyperglycemia at an early
stage of adulthood (6). However, with a C57BL/6J background, the fasting blood
glucose level of the MafA knockout mice was comparable to that of WT mice even at
a later stage of adulthood (7). In addition, although MafA knockout mice from the ICR
strain developed diabetes as a result of long-term fasting hyperglycemia (6), MafA
knockout mice from the C57BL/6J strain displayed only impaired blood glucose toler-
ance and did not show any other severe phenotype. Since the deletion of MafA from
the C57BL/6J mice was successful (see Fig. S1A and B), we thought that, in the C57BL/6J
mouse strain, deﬁciency of MafA alone was not enough to induce the impact of MafB
on adult  cells. Hence, in order to induce a more pathological condition, we treated
the mice with an HFD to develop a diabetic phenotype.
Body weight and fasting blood glucose levels were measured before and after the
HFD treatment. Feeding an HFD increased the body weights of all the groups to the
same degree (Fig. 4A). Fasting blood glucose levels of A0B0 mice tended to be higher
and were elevated signiﬁcantly compared to the other groups 4 months after initiating
an HFD (Fig. 4B). Glucose tolerance was severely impaired in the A0B0 mouse group, as
the blood glucose level remained signiﬁcantly higher even at 4 h post-glucose admin-
istration (800 mg/dl) (Fig. 4C).
FIG 4 Blood glucose tolerance is severely impaired in A0B0 mice under HFD treatment. (A and B) Body weights and
fasting blood glucose levels from mice with different genotypes during the 5-month HFD feeding period. The mice
were fed an HFD from 8 weeks of age. The data are from 3 or 4 male mice of each genotype. (C) Glucose tolerance
tests (ipGTT) after intraperitoneal loading with 2 g glucose/kg were performed on male mice of the indicated
genotypes following a 16-h fast after 5 months of HFD treatment. (D) An in vivo glucose-stimulated insulin secretion
(GSIS) test after intraperitoneal loading with 3 g glucose/kg was performed on 5-month-HFD-treated male mice of
the indicated genotypes following a 16-h fasting period. The data are from 3 or 4 male mice of each genotype. *,
A0B2 and WT, P 0.05; **, A0B02 and WT, P 0.01; #, A0B0 and WT, P 0.05; ##, A0B0 and WT, P 0.01; ※, A0B2
and A0B0, P 0.05; ※※, A0B2 and A0B0, P 0.01. The error bars indicate SD.
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In addition, A0B0 mice started to show symptoms of diabetes, such as frequent
urination with a high urine glucose level (data not shown). Two of them died because
of this severe condition.
Total islet number is decreased and islet size is not properly maintained in
HFD-treated A0B0 mice. We next analyzed the pancreatic islets histologically by
hematoxylin-and-eosin (H&E) staining (Fig. 5A). The numbers and sizes of the islets
were quantiﬁed in WT, A0B2, and A0B0 mice. Islets were divided into 3 groups
according to their size—(i) small islets (less than 100 m in diameter), (ii) medium-size
islets (100 m to 200 m in diameter), and (iii) large islets (more than 200 m in
diameter)—and their proportions in each mouse group were calculated. The percent-
ages of large islets were decreased signiﬁcantly in the A0B2 and A0B0 groups compared
to that in the WT group (WT, 27% 5.7%; A0B2, 11% 4.2%; A0B0, 4% 0.6%), while
they were comparable to each other. Middle-sized islets, on the other hand, were
almost equally distributed in all 3 groups. Interestingly, we found that the percentage
of small islets was signiﬁcantly higher in the A0B0 group than in the WT group, while
it remained comparable to that in the A0B2 mouse group (WT, 22% 9.4%; A0B2,
45% 6.1%; A0B0, 60% 6.5%) (Fig. 5B). The total number of islets in the A0B0 mouse
group dropped signiﬁcantly compared to the WT mice (WT, 16 7.5; A0B0, 8 2.9)
(Fig. 5C). To sum up, small islets made up a larger proportion and large islets made up
a smaller proportion in the A0B0 mouse group than in any other group, while the total
number of islets was also signiﬁcantly decreased in that group.
Insulin-positive cell numbers are signiﬁcantly decreased in HFD A0B0 mice.We
next analyzed the islet structure of HFD-treated mice by staining the islets with insulin
and glucagon antibodies. Insulin-positive cells showed a drastic reduction in number in
the A0B0 group compared to those in the WT and A0B2 groups (the percentages of
insulin cells per islet were as follows: WT, 76% 3.2%; A0B2, 59% 8.2%; A0B0,
37% 7.9%) (Fig. 6A and B). To determine if the reduced number of insulin cells in
A0B0 mice was due to decreased cell proliferation and/or increased cell apoptosis, we
stained the islets with Ki67 (a proliferative-cell marker) and cleaved caspase 3 (an
apoptotic-cell marker) antibodies, respectively. Ki67 signaling could be observed at
FIG 5 A0B0 mice with an HFD had decreased total islet numbers, and the islets failed to properly expand. (A)
Hematoxylin-and-eosin staining of mice from different genotypes after 5 months of HFD feeding. (B) Morphometric
analysis of islet diameters in pancreases from each mouse group after 5 months of HFD feeding. (C) Total islet
numbers in pancreases from each mouse group. The data are from 3 or 4 mice of each genotype. *, P 0.05; **,
P 0.01; NS, not signiﬁcant. The error bars indicate SD.
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E18.5 in insulin cells (see Fig. S4A in the supplemental material), as the cells are highly
proliferative during embryonic development. However, there were no detectable Ki67
cells in the islets of any mouse group with 5-month HFD treatment (see Fig. S4A).
Cleaved caspase 3 cells, on the other hand, were signiﬁcantly increased by proportion
in the islets of the A0B0 group compared to those of the WT group (the percentages
of cleaved caspase 3 cells per islet were as follows: WT, 11% 2.2%; A0B2,
19% 0.5%; A0B0, 31% 8.5%) (Fig. 6C and D), indicating cell apoptosis is more
highly induced in A0B0 islets. Finally, total islet cell numbers per islet in the A0B0 mice
showed a signiﬁcant reduction compared to those in the WT mice, while they were
comparable to those in the A0B2 mice (Fig. 6E). This might due to the increased number
of small islets in the A0B0 mouse group (Fig. 5B).
DISCUSSION
In this study, we generated and analyzed mice with single and compound knockouts
of MafA and MafB to determine the role of MafB in adult  cells under MafA knockout
conditions. Several main observations on pancreatic function and islet morphology are
reported here. First, A0B0 adult mice displayed more severely impaired glucose toler-
ance than A0B2 mice. This phenomenon was further aggravated with HFD treatment,
which caused diabetes in the A0B0 mice. Second, deﬁciency of MafA has a destructive
effect on normal islet structure, and moreover, the abnormality becomes more signif-
icant with the deletion of MafB. Third, a notable reduction in islet cell numbers,
together with an increase of -cell apoptosis, was detected in HFD-fed A0B0 mice.
FIG 6 Insulin production is severely impaired in islets of A0B0 mice compared to WT and A0B2 mice. (A) Insulin
(green) and glucagon (red) immunoreactivities in mouse pancreatic islets from each genotype after HFD treatment.
(B) Insulin-positive cell number/total islet cell number ratio in pancreatic islets of each mouse group. (C) Cleaved
caspase 3 (green) and insulin (red) immunoreactivities in mouse pancreatic islets from each genotype after HFD
treatment. Scale bars, 100 m. (D) Cleaved caspase 3-positive cell number/total islet cell number ratio in pancreatic
islets of each mouse group. (E) Total islet cell number per pancreatic islet of each mouse group. The data are from
3 or 4 mice of each genotype. *, P 0.05; **, P 0.01. The error bars indicate SD.
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Therefore, our ﬁndings provide evidence for a functional role of MafB in maintaining
mature -cell features under some speciﬁc pathological conditions.
As a key regulator for -cell and -cell development and mature -cell function,
deletion of MafB speciﬁcally from  cells only delayed -cell development, as expected
(Fig. 1A). During embryogenesis, MafB is not only required for the transcription of Ins1
and Ins2, it also important for maintaining a normal expression level of key -cell genes,
such as Pdx1 and Glut2, since deletion of MafB resulted in a reduction of expression of
the above-mentioned genes (11, 12), thereby affecting normal -cell development.
MafB’s effect on  cells gradually decreases after birth (Fig. 1C to E), along with
increased expression of MafA in  cells, due to the MafB-to-MafA transition being
crucial for -cell functional maturation (5).
Deletion of MafA, on the other hand, resulted in reduced Ins1, Ins 2, and Pdx1
transcription in adult mice, which further led to impaired glucose tolerance and
glucose-stimulated insulin secretion. These results are consistent with previous studies
demonstrating that MafA regulates glucose-stimulated insulin secretion by promoting
transcription of Insulin and other genes related to -cell genes (6, 13–18). Interestingly,
the fasting blood glucose concentration was sustained at a normal level as a control in
this study, while we found in our previous study (6) that MafA-deﬁcient mice developed
diabetes because of hyperglycemia. Since the MafA KO mice were based on the
C57BL/6J strain in the present study while Zhang et al. used the ICR strain, they were
generated from different genetic backgrounds, and strain differences could explain the
phenotypic variations. Almost the same result was reported by Nishimura et al. (7).
Deletion of MafA and MafB together aggravated the metabolic phenotype of MafA
single-knockout mice. More impaired glucose intolerance in A0B0 mice than in A0B2
mice was observed under normal diet conditions, which was severely aggravated by
HFD feeding and led to diabetes mellitus in the double-knockout mice. The under-
mined glucose tolerance was due to either normal insulin production being affected,
which results in reduced insulin content, or normal insulin release in response to an
elevated blood glucose level being impaired. Neither the whole pancreatic insulin
content nor the glucose-stimulated insulin secretion showed signiﬁcant differences
between the A0B2 and A0B0 mice under normal diet conditions. Interestingly, the
-cell/-cell ratio became remarkably higher in the A0B0 islets than in the A0B2 islets.
Impaired islet structure is one of the signiﬁcant phenotypes of MafA-deﬁcient mice (6),
but the molecular mechanisms leading to this structural abnormality have not been
clariﬁed. Since this abnormality became more remarkable in the A0B0 group, we
assumed it could explain the more impaired glucose tolerance in A0B0 mice than in
A0B2 mice under normal diet conditions. Interestingly, Cyphert et al. showed that
expressing the MafB homodimer in MafAΔ (with MafA speciﬁcally deleted in  cells)
mice resulted in the same phenotype as MafAΔ mice with impaired islet structure, and
their glucose tolerance was not rescued by MafB expression (19). Taken together with
our results, this shows that MafB has other unique properties rather than just acting as
a compensatory factor for MafA to maintain adult -cell function.
Since conversions between  and  cells were reported in previous studies (20, 21),
it is possible that MafB could be deleted from -cell-converted  cells or vice versa in
the present study. However, there were no double-positive Pdx1 or glucagon cells in
the islets of any mouse group (see Fig. S3A in the supplemental material), indicating
conversions of glucagon-producing cells to insulin-producing cells had not occurred at
a noticeable level. This was further conﬁrmed by Pdx1/Arx staining (see Fig. S3B).
In addition, all the insulin-positive cells were Pdx1 positive in the islets of all three
groups (see Fig. S3C). Taken together, these results suggest that there is no obvious cell
conversion in A0B0 islets. As downstream transcription factors for islet endocrine cell
differentiation, deletion of MafA and MafB may have a small effect on cell fate
determination.
Realizing that, on a C57BL/6J background, a deﬁciency of MafA alone was not
sufﬁcient to show the possible role of MafB in maintaining adult -cell function, we
implemented HFD treatment for mice to induce obesity and obtain a more severe
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phenotype. As a result, insulin cell numbers showed a dramatic reduction in A0B0
islets, while glucose-stimulated insulin secretion levels were comparable between the
A0B2 and A0B0 groups (Fig. 4D), indicating that critically damaged insulin production
ability of  cells could be a reason for A0B0 mice to become extremely glucose
intolerant and to develop diabetes. Nevertheless, their insulin content needs to be
measured to conﬁrm this conclusion.
In insulin resistance disorders caused by adiposity or gestation, the -cell mass
increases to adapt to the body’s increased requirement for insulin, which results in
enlarged islets and increased islet numbers (22–26). Generally, the -cell mass is
regulated by -cell proliferation and -cell apoptosis (27). Previous studies found that
MafB expression is induced in proliferative  cells during pregnancy and in obesity (28,
29), suggesting MafB may play a unique role in -cell adaptation under certain
metabolic stresses that demand more insulin production. Deﬁciency of MafA under
HFD conditions is harmful enough to cause insulin insensitivity in the body. We
speculate that removing MafB from  cells further inhibits the -cell mass from
expending by increasing islet numbers and islet size. The drastic reduction in insulin
 cells in A0B0 mice supports our hypothesis. However, we failed to detect and
compare the -cell proliferation in the islets of WT, A0B2, and A0B0 mice with that in
mice undergoing 5-month HFD treatment (Fig. S4A). Adaptive -cell proliferation has
been reported to start within the ﬁrst week of HFD treatment (30). Therefore, it might
be already completed by 5 months after the beginning of HFD treatment. That is why
we could not detect -cell proliferation at this period. On the other hand, we clearly
detected an increase of -cell apoptosis in A0B0 islets (Fig. 6C and D). Although this was
an unexpected result, it may be reasonable, because MafB is known to be a regulator
to prevent apoptosis in macrophages under speciﬁc conditions, as we reported previ-
ously (31). Therefore, this ﬁnding provides a whole new perspective on MafB function
in pancreatic  cells.
Finally, unlike rodents, where MafB expression in  cells declines postnatally, MAFB
is expressed in human  cells along with MAFA throughout adulthood (8, 32), implying
its importance in maintaining mature human -cell function. To mimic the human
condition in mice, Cyphert et al. overexpressed MafB in mouse adult  cells using
MafA transcriptional-control sequences. However, no overt metabolic effect was
observed upon coexpression of MafA and MafB, indicating MafA-MafB heterodimers
can function like MafA homodimers to regulate human adult  cells (19). Notably,
overexpressing MafB in human -cell lines (TC3 cells) resulted in increased cell
proliferation by upregulating important cell cycle regulators, like cyclin D2 and
cyclin B (28). MafB expression has also been found to be acutely decreased in type
2 diabetic humans (33). Taken together, the data show that reduced expression of
MafB in human islets may impede the proliferation of  cells that is normally
triggered by increased metabolic stress and stimulate apoptosis, as we demonstrate
in this paper, leading to diabetes mellitus. The detailed molecular mechanisms need
further investigation.
To sum up, A0B0 mice became more susceptible to diabetes under HFD conditions,
with impaired islet morphology and decreased insulin-expressing cell numbers because
of apoptosis, indicating MafB is important for pancreatic -cell maintenance under
speciﬁc pathological conditions.
MATERIALS AND METHODS
Mice. All experimental mice were maintained under speciﬁc-pathogen-free conditions in the Labo-
ratory Animal Resource Center at the University of Tsukuba, Ibaraki, Japan. All experiments were
performed according to the relevant Japanese and institutional laws and guidelines and approved by the
University of Tsukuba Animal Ethics Committee (authorization number 14-189). The C57BL/6J mouse
strain from the Jackson Laboratory was used in this study.
Generation of A0B0 mice. MafA-deﬁcient (A0) mice were generated as previously described (6).
Pancreatic--cell-speciﬁc deletion mutants of MafB (B0) were generated by crossing MafBﬂox/ﬂox (34, 35)
mice with Ins1-Cre mice (36), which produced Cre in pancreatic  cells. A0B0 mice were generated by
crossing A0 mice with B0 mice.
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High-fat diet. MafA single-knockout (A0B2) and MafA and MafB double-knockout (A0B0) mice and
their WT littermates were fed an HFD consisting of 62.2% fat, 19.6% carbohydrate, and 18.2% protein
content on a caloric basis (Oriental Yeast, Japan) from 6 to 8 weeks of age.
Immunohistochemistry. Pancreatic tissues obtained from WT, A0B2, and A0B0 mice were ﬁxed in
4% paraformaldehyde overnight at room temperature and embedded in parafﬁn. The sections were then
deparafﬁnized in xylene (Fujiﬁlm, Japan) 3 times for 5 min each, followed by rehydrating in graded
ethanol (100% [5 min] and 95%, 85%, 70%, and 50% [2 min each]). They were placed in tap water for 5
min and then in phosphate-buffered saline (PBS) for 5 min (3 times) and blocked with PBS containing
10% goat serum with 0.03% preservative sodium azide for 1 h at room temperature. Then, they were
incubated with guinea pig anti-insulin (1:100; ab7842; Abcam), rabbit antiglucagon (1:500; 2760; Cell
Signaling), rabbit anti-MafA (1:100; Bethyl), rabbit anti-Pdx1(1:500; Chemicon), rabbit anti-Arx (1:250; a
generous gift from Kunio Kitamura and Kenichirou Morohashi, Kyushu University, Japan), rabbit anti-
MafB (1:100; IHC-00351; Bethyl), rabbit anti-Ki67 (1:200; Novocastra), and rabbit anti-cleaved caspase 3
(D175; Cell Signaling) overnight at 4°C. After rinsing, the slides were incubated with Alexa Fluor-
conjugated secondary antibodies (anti-guinea pig antibody–Alexa Fluor 594 for insulin; anti-rabbit
antibody–Alexa Fluor 488 for glucagon and cleaved caspase 3; and anti-rabbit antibody–Alexa Fluor 594
for MafA, Pdx1, Arx, Ki67, and MafB; 1:1,000; Life Technologies) for 2 h at room temperature. Tissue
specimens were mounted with Fluoromount (Diagnostic Biosystem). All images were acquired on a
ﬂuorescence microscope (Biorevo BZ-9000; Keyence).
Cell counting. Following immunoﬂuorescence staining, the different cell types in each islet were
manually counted in the islet microscopy images. For each cell type, 10 to 30 representative islets from
3 or 4 mice per group were counted. To calculate the fraction of hormone cells within the islets, the
number of hormone cells per islet was manually determined using ImageJ software and divided by the
total number of Hoechst nuclei from the same islet.
Islet counting and islet size measurement. Pancreatic tissue 5-m parafﬁn sections obtained from
WT, A0B2, and A0B0 mice were stained by routine H&E staining. Islets in each section were manually
counted in the islet microscopy images. Islet diameters were measured using ImageJ software.
Pancreatic insulin and glucagon content measurement.Whole pancreases obtained from the WT,
A0B2, and A0B0 mice were weighed and chopped into small pieces in 6 ml ice-cold acid-ethanol (1.5%
HCl in 75% ethanol). The tissues were then sonicated for 30 s (duty cycle, 20%; output control, 20) and
stored overnight at 4°C, followed by a second round of sonication the next day. The supernatants were
collected after centrifuging the samples at 2,400 rpm for 30 min at 4°C. The total protein concentration
was measured with a Coomassie protein assay reagent (Thermo Scientiﬁc). Insulin and glucagon contents
were measured by enzyme-linked immunosorbent assay (ELISA) (Morinaga mouse insulin ELISA kit
[M1102]; Mercodia glucagon 10-l ELISA kit [10-1281-OD]). Each pancreatic content was normalized by
the total protein concentration per sample.
Intraperitoneal glucose tolerance test. Mice were fasted for 16 h and given glucose (2 g/kg body
weight) by intraperitoneal injection. Blood samples were obtained from the tail vein at the indicated
times (0, 15, 30, 60, and 120 min after injection) and then measured with a glucometer (Terumo, Japan).
In vivo glucose-stimulated insulin secretion (GSIS) experiment. Mice were fasted for 16 h and
given glucose (3 g/kg) by intraperitoneal injection. Blood was collected into heparinized tubes from the
facial vein at 2 min after glucose injection. Plasma insulin levels were measured with an insulin ELISA kit
(Morinaga mouse insulin ELISA kit).
Isolation of pancreatic islets. Pancreatic islets were isolated from 9-month-old female WT, A0B2,
and A0B0 mice as previously described (9).
Quantitative real-time PCR. Total RNA was extracted in Isogen (Nippon Gene) from isolated
pancreatic islets of female WT, A0B2, and A0B0 mice. cDNA was synthesized according to the protocol
of the QuantiTect reverse transcription kit (Qiagen). Real-time PCRs were performed in duplicate on a
Thermal Cycler Dyce real-time system (Takara). The expression levels of all the target genes were
normalized to that of Hprt. The primers used in this study are listed in Table 1.
TABLE 1 Primer sequences for real-time quantitative PCR
Gene Orientationa Sequence (5=¡3=)
Mafa F GCTGCTGCACCCGCTTGAAG
R AGGCCACCACGTGCGCTTGG
Ins1 F CCAGCTATAATCAGAGACCA
R GGGCCTTAGTTGCAGTAGTT
Ins2 F AGGAAGCCTATCTTCCAGGT
R ATTCATTGCAGAGGGGTAGG
Gcg F AGGGACCTTTACCAGTGATGT
R AATGGCGACTTCTTTGGGAA
Hprt F TTGTTGTTGGATATGCCCTTGACTA
R AGGCAGATGGCCACAGGACTA
aF, forward; R, reverse.
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Statistical analysis. Results were expressed as means and standard deviations (SD). Statistical
comparisons between two groups were made using Student’s t test, and comparisons among three
groups were made using one-way analysis of variance (ANOVA) with post hoc Tukey honestly signiﬁcant
difference (HSD) tests. A statistically signiﬁcant difference was deﬁned as a P value of 0.05.
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